Dihexa
Angiotensin IV analog studied in synaptogenesis and HGF/c-Met receptor research.
Dihexa is supplied by Bench Grade Peptides as a lyophilized powder in a sealed, lot-numbered vial, for laboratory research use only — not for human or veterinary use.
No Certificate of Analysis is published for this product yet; certificates appear in the public COA library once the third-party laboratory report is in. Vials ship at ambient temperature in protective packaging from Florida (Bench Grade Peptides LLC is registered in Dover, Delaware).
Angiotensin IV analog studied in synaptogenesis and HGF/c-Met receptor research.
The primary literature on this compound includes McCoy et al., J Pharmacol Exp Ther (2013). The references below link directly to the published record.
Lots are synthesized in the USA and verified by HPLC; where a lot's Certificate of Analysis is published, it is in the COA library. It is supplied strictly for laboratory research use.
Published research
- The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseasesWright JW, et al. Prog Neurobiol. 2015.PubMed →
- The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system
Further reading in the lab library
Researchers also ordered
- ARA-290Erythropoietin-derived 11-residue research peptide studied in neuropathy and tissue-protection literature.
- CartalaxSynthetic peptide bioregulator studied in joint and cartilage research models.
- DSIPDelta-sleep-inducing nonapeptide studied in sleep-architecture research.
- PinealonPineal-gland-derived synthetic tripeptide studied in cognitive-aging research.

